EUVIMED · CrossrefJournal
Pharmaceutical Medicine
ISSN 1178-2595 · Springer Science and Business Media LLC
Latest articles
Perceptions of Australian Medical Affairs and Cross-Functional Participants on the Role of Medical Affairs in Quality Use of Medicines (QUM)
Regulatory Pathways and Pivotal Trial Characteristics of Medicines Designated under the European Medicines Agency’s Priority Medicines Scheme Approved between 2018 and 2024
Eight Hallmarks for Governing Artificial Intelligence in Medical Affairs: A Structured Pathway for Responsible AI Adoption
From Invisible to Enrolled: How Artificial Intelligence Is Reshaping Clinical Trial Recruitment
An Expert Consensus-Based Review of Considerations for Developing a Quality Management System Framework for Studies Utilising Secondary Data for Real-World Evidence Generation
Optimising Formulations for Paediatric Patients with Inherited Metabolic Disorders: The Case Study of Levocarnitine
Changes in Saccadic Hypometria over Time to Monitor Parkinson’s Disease Progression
Language as an Eligibility Criterion in Pediatric Study Protocols Conducted in Europe (2007–2024) Reported in the ClinicalTrials.gov Database
Regulating the Irregular: Phage Therapy and the Case for a Regulatory Sandbox Approach in Australia
A Framework for Standardising Toxicity Management Guidelines in Oncology Clinical Trials
Correction: Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Development of a Taste-Masked, Dose-Flexible, Multiparticulate Pediatric Dosage Form: Case Study of Crizotinib, a Challenging Pediatric Formulation
Transformation of a Medical Information Department to Meet the New Healthcare Realities of the Post-Pandemic Era
Association Between Survival Benefits of Anticancer Drugs and Probability of US Food and Drug Administration Approval: A Systematic Review
Paediatric Phase I/II Clinical Trial Assessments Under the New EU Clinical Trial Regulation: A Descriptive Analysis
Evaluation of the Quality Decision-Making Practices Utilized by the Zambia Medicines Regulatory Authority Technical Committees
Sponsor Initiated Requests to Delay Pediatric Postmarketing Studies
Correction: Acknowledgement to Referees
Development of a Competency Framework for Medical Affairs Professionals in Australasia
Awareness and Experience of Direct Healthcare Professional Communication and Risk Management Plan Educational Material among Healthcare Professionals in Finland
The Utilization, Reimbursement, and Cost of Targeted Therapies for Duchenne Muscular Dystrophy (DMD) in US Medicaid Programs: A Descriptive Trend Analysis from 2017 to 2022
Professional Competencies and Capabilities in the Development of Medicines
Artificial Intelligence: Applications in Pharmacovigilance Signal Management
Disproportionality Analysis and Causal Inference in Drug Safety
Transdermal Drug Delivery Systems: Different Generations and Dermatokinetic Assessment of Drug Concentration in Skin
Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities
Endpoints for Pharmacotherapy Trials for Alcohol Use Disorder
How Can General Managers Best Leverage Medical Affairs Now and in the Future?
Increasing Diversity, Equity, Inclusion, and Accessibility in Rare Disease Clinical Trials
The Importance of Assessing Drug Exposure and Medication Adherence in Evaluating Investigational Medications: Ensuring Validity and Reliability of Clinical Trial Results
EUVIMED